Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
14th Clinical Trials on Alzheimer's Disease (CTAD) Conference
November 09 - 12, 2021; Boston, MA
November 09 - 12, 2021Boston, MA
CTAD 2021Blood Test May Detect Preclinical Alzheimer's Years in AdvanceA new blood test that identifies a variant of the protein P53 appears to predict Alzheimer's disease progression up to 6 years in advance of a clinical diagnosis, early research suggests.
CTAD 2021Sensory Stimulation Promising for Alzheimer's DiseaseSensory stimulation, which elicits gamma oscillations that affect brain structure and cognition, is safe and effective for treating Alzheimer's disease symptoms, a proof-of-concept study suggests.